The invention provides certain 3,4-dihydroisoquinolin-2(1H)-yl compounds, particularly compounds of formula (I), and pharmaceutical compositions thereof. The invention further provides methods of using a compound of formula (I) to treat cognitive impairment associated with Parkinson's disease or schizophrenia.
本发明提供了某些
3,4-二氢异喹啉-2(1H)-基化合物,尤其是式(I)化合物及其制药组合物。本发明还提供了使用式(I)化合物治疗与帕
金森病或精神分裂症相关的认知障碍的方法。